Oncogenic MORC2 in cancer development and beyond
- PMID: 37692502
- PMCID: PMC10491978
- DOI: 10.1016/j.gendis.2023.05.010
Oncogenic MORC2 in cancer development and beyond
Abstract
Microrchidia CW-type zinc finger 2 (MORC2) is a member of the MORC superfamily of nuclear proteins. Growing evidence has shown that MORC2 not only participates in gene transcription and chromatin remodeling but also plays a key in human disease and tumor development by regulating the expression of downstream oncogenes or tumor suppressors. The present review provides an updated overview of MORC2 in the aspect of cancer hallmark and therapeutic resistance and summarizes its upstream regulators and downstream target genes. This systematic review may provide a favorable theoretical basis for emerging players of MORC2 in tumor development and new insight into the potential clinical application of basic science discoveries in the future.
Keywords: Cancer development; Hallmarks of cancer; MORC2; Therapeutic target; Treatment resistance.
© 2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
Figures
References
-
- Inoue N., Hess K.D., Moreadith R.W., et al. New gene family defined by MORC, a nuclear protein required for mouse spermatogenesis. Hum Mol Genet. 1999;8(7):1201–1207. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
